Law360 (April 26, 2021, 6:37 PM EDT) — Special purpose acquisition companies have been around for decades, but the practice of taking a company public with a SPAC instead of as a traditional initial public offering has recently exploded in popularity, especially in the first few months of 2021.One driver of the popularity of SPACs is the perception that they have lower liability risks than traditional IPOsBut a closer look at SPAC transactions suggests that the liability risks are not as low as some believe.

[…]

Read More…

The House of Representatives has passed the “The Promoting Transparent Standards for Corporate Insiders Act” (H.R. 1528) by a vote of 355-69.  The bill directs the Securities and Exchange Commission to study and report on possible revisions to regulations regarding 10b5-1 trading plans. 10b5-1 plans allow employees of publicly traded companies and others to sell their shares without violating insider trading prohibitions. The bill requires the SEC to revise its regulations consistent with the results of the study.

[…]

Read More…

The Securities and Exchange Commission today announced that it filed an emergency action and obtained a temporary restraining order and an asset freeze to stop an alleged Ponzi scheme and misappropriation of investor proceeds perpetrated by Melbourne, Florida resident Jonathan P. Maroney through several entities he controls.

According to the SEC’s complaint, which was filed in federal court in the Middle District of Florida, since about May 2015, Maroney and his companies raised at least $17.1 million from more than 100 investors in a series of fraudulent securities offerings. The complaint alleges that Maroney, his company Harbor City Capital Corp., and his various other entities told investors that offering proceeds would be used to finance the defendants’ online “customer lead generation campaigns,”  and promised investors annual returns ranging from 10% to 60% from the resale of those leads to other businesses. In fact, according to the complaint, little if any investor funds actually went to the lead generation business. Instead, the complaint alleges, Maroney misappropriated at least $4.48 million in investor funds to enrich himself and his family, including the purchase and maintenance of his waterfront home and a Mercedes Benz, and to pay for his extensive credit card bills and renovation-related expenses on the house. The complaint further alleges that Maroney misused investor money by making payments to other entities unrelated to the supposed purpose of the offerings, and that he fraudulently used investor funds to make monthly interest payments and other payouts to investors in a classic Ponzi scheme fashion.
“As alleged in our complaint, Maroney lured investors with promises of double-digit returns and false claims, while pocketing millions of investor dollars for himself,” said Eric I. Bustillo, Director of the SEC’s Miami Regional Office.  “Investors should be skeptical of any investment that promises extraordinarily high rates of return.”
The SEC’s complaint, filed on April 20, 2021, and unsealed today, charges the defendants with violating the antifraud and registration provisions of the federal securities laws. In addition to the emergency relief granted by the Court, the complaint seeks preliminary and permanent injunctions, disgorgement, prejudgment interest, and a civil penalty from each of the defendants. The complaint also names Tonya Maroney, Maroney’s wife, and Celtic Enterprises LLC, another Maroney-controlled entity, as relief defendants for receiving proceeds from the alleged fraud. The Court set a hearing for April 29, 2021, to determine if a preliminary injunction should be entered and whether the asset freeze should remain in force for the duration of the litigation.
The SEC’s investigation was conducted by Brian Theophilus James and Kathleen Strandell in the Miami Regional Office, and was supervised by Chedly C. Dumornay and Glenn S. Gordon. The SEC’s litigation will be led by Alise Johnson. The SEC acknowledges the assistance of the Florida Office of Financial Regulation.

[…]

Read More…

LIMA, Peru, April 26, 2021 /PRNewswire/ — Intercorp Financial Services Inc. (“IFS” or “the Company”) (BVL/NYSE: IFS) announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2020 (the “2020 Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”).
With the filing of its 2020 Annual Report, the Company complies with its reporting obligations with the SEC and the New York Stock Exchange (NYSE).
The 2020 Annual Report includes the audited consolidated financial statements of the Company in accordance with International Financial Reporting Standards (IFRS) as adopted by the International Accounting Standards Board and its auditors’ opinion on IFS’ compliance with internal control over financial reporting.
The 2020 Annual Report can be accessed by visiting the SEC’s website, www.sec.gov, and can also be found on IFS’ website, www.ifs.com.pe, under the “Investor Relations” section, “SEC Filings” subsection. In addition, shareholders may receive a hard copy of the 2020 Annual Report, including the audited consolidated financial statements included in such report, free of charge, by requesting a copy within a reasonable period of time from IFS’ Investor Relations Office, at [email protected].
Any inquiries can be directed to Ernesto Ferrero, IFS’ Investor Relations Officer, at [email protected].
About the Company:Intercorp Financial Services Inc. (“IFS”), is a company incorporated under the laws of the Republic of Panama, and has securities listed on the Lima Stock Exchange and the New York Stock Exchange. IFS is a leading provider of financial services in Peru. IFS’ main subsidiaries are Banco Internacional del Perú, S.A.A.-Interbank (“Interbank”), Interseguro Compañía de Seguros, S.A. (“Interseguro”) and Inteligo Group Corp. (“Inteligo”). Interbank is a full-service bank providing general banking services to retail and commercial customers. Interseguro is a leading insurance company, providing annuities, individual life insurance, disability insurance and survivor benefits, and mandatory traffic accident insurance. Inteligo is a fast-growing provider of wealth management services through Inteligo Bank Ltd. and Interfondos, as well as brokerage services through Inteligo SAB.
This release contains statements that may be considered forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. All forward-looking statements, whether made in this release or in future filings or press releases or orally, address matters that involve risks and uncertainties, including in respect of the Company’s business, financial condition, results of operations and certain of its plans, objectives, assumptions, projections, expectations or beliefs and statements regarding other future events or prospects. These statements include, without limitation, those concerning: the Company’s strategy and ability to achieve it; expectations regarding sales, profitability and growth; possible or assumed future results of operations; capital expenditures and investment plans; adequacy of capital; and financing plans; potential exposure to various types of market risks, such as macroeconomic risk, Peru specific risks, foreign exchange rate risk, interest rate risks and other risks related to financial performance.  We do not intend, and do not assume any obligation to update these forward-looking statements.

For more information, please visit www.ifs.com.pe, or contact us:

Mr. Ernesto Ferrero, Investor Relations Officer

Mr. Jorge Orihuela, Investor Relations Analyst

[email protected]

[email protected]

Tel: (511) 219-2000 x. 29025

Tel: (511) 219-2000 x. 29029

Intercorp Financial Services Inc.

Torre Interbank, Carlos Villaran 140

Lima 13, Peru

SOURCE Intercorp Financial Services Inc.

Related Links
https://ifs.com.

[…]

Read More…

Related Content

Five Star Bancorp files registration to go public

Santa Cruz County Bank hires Sacramento SBA lending veterans

Most Admired CEO honoree: James Beckwith of Five Star Bank

40 Under 40 honoree: Jen Matulich with Five Star Bank

40 Under 40 honoree: Lydia Ramirez with Five Star Bank

[…]

Read More…

SEATTLE, April 26, 2021 /PRNewswire/ — RealNetworks, Inc. (NASDAQ: RNWK) (“RealNetworks”), today announced that it has commenced a proposed underwritten public offering of its common stock pursuant to RealNetworks’ shelf registration statement. In connection with this offering, RealNetworks expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the offering price, less underwriting discounts and commissions, to cover over-allotments, if any. RealNetworks intends to use the net proceeds of the offering for working capital and general corporate purposes. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Lake Street Capital Markets, LLC is acting as sole book-running manager for the offering.

A shelf registration statement on Form S-3 relating to the common stock offered in the public offering described above was filed with the Securities and Exchange Commission (the “SEC”) and became effective on April 15, 2021. The offering is being made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC’s website at www.sec.gov. A final prospectus supplement and accompanying prospectus will be filed with the SEC. Copies of the preliminary prospectus supplement and the accompanying prospectus, and when available, copies of the final prospectus supplement and the accompanying prospectus, may also be obtained from Lake Street Capital Markets, LLC, 920 2nd Ave South, Suite 700, Minneapolis, Minnesota 55402.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of the securities being offered in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About RealNetworks

Building on a legacy of digital media expertise and innovation, RealNetworks has created a new generation of products that employ best-in-class artificial intelligence and machine learning to enhance and secure our daily lives. Real’s business and product portfolio includes the Kontxt semantic analysis platform and SAFR (www.safr.com), which is the world’s premier facial recognition platform for live video. Leading in real-world performance and accuracy as evidenced in testing by NIST, SAFR enables new applications for security, convenience, and analytics. For information about all of our products, visit www.realnetworks.com.

RealNetworks is a registered trademark of RealNetworks, Inc. All other trademarks, names of actual companies and products mentioned herein are the property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements include, among other things, statements regarding RealNetworks’ expectations on the timing, size and completion of the offering, the amount of proceeds expected from the offering and the anticipated use of proceeds therefrom. These forward-looking statements are distinguished by use of words such as “may,” “expect,” “will,” “plan,” or “intend,” the negative of these terms, and similar references to future periods. These statements involve risks and uncertainties that could cause actual results to differ materially, including, but not limited to, whether or not RealNetworks will be able to consummate the offering of common stock described herein, including due to the satisfaction of customary closing conditions and prevailing market conditions, the anticipated use of the proceeds of the offering which could change as a result of market conditions or for other reasons, and the impact of general economic, industry or political conditions in the United States or internationally, including the impact of COVID-19. Additional risks and uncertainties relating to the proposed offering, RealNetworks and its business can be found under the heading “Risk Factors” in RealNetworks’ most recent periodic, quarterly and annual reports filed with the SEC and in the preliminary prospectus supplement and accompanying prospectus relating to the offering to be filed with the SEC. RealNetworks assumes no duty or obligation to update or revise any forward-looking statements for any reason.

For More Information: 

Investor Relations for RealNetworks

Kimberly Orlando, Addo Investor Relations

310-829-5400

SOURCE RealNetworks, Inc.

[…]

Read More…

PITTSBURGH, April 26, 2021 /PRNewswire/ — Federated Hermes, Inc. (NYSE: FHI), a global leader in active, responsible investing, announced that it reached an agreement to acquire certain investment management related assets of Horizon Advisers and reorganize the portfolios of all nine Hancock Horizon mutual funds into comparable Federated Hermes mutual funds. Through the agreement, approximately $568 million1 in seven equity and two municipal bond funds will transition to one new and six existing much larger Federated Hermes mutual funds with comparable investment objectives and strategies (see page 2 for a list of funds). Horizon Advisers, an unincorporated division of Hancock Whitney Bank, serves as investment advisor to the Hancock Horizon Funds.
A similar transaction was completed in 2017, when three Hancock Horizon mutual funds were reorganized into comparable Federated Hermes mutual funds. “Federated Hermes is experienced in managing these types of transactions and has a history of providing investment solutions for a variety of market conditions,” said Chief Investment Officer for Horizon Advisers David Lundgren. “We at Hancock Advisers are confident in our selection of Federated Hermes as a partner in this transaction, and their actively managed funds serve as a sensible new home to these assets. We also believe that as other shareholders of these nine funds learn about the Federated Hermes mutual funds and focus on their own financial goals and objectives, they will benefit from the opportunity to access Federated Hermes’ range of strategies.”
The board of directors of Federated Hermes, Inc., the boards of directors/trustees of the Federated Hermes Funds and the board of trustees of the Hancock Horizon Funds have approved the transaction and related reorganizations, which are now subject to the approval by shareholders of the Hancock Horizon Funds. Completion of these transactions also is subject to certain regulatory approvals and other customary conditions. The Hancock Horizon shareholder meetings to approve the transitions are tentatively scheduled for September 2021, and the transactions are expected to be completed shortly thereafter.

“Federated Hermes aims to provide solid product performance through a range of compelling active, responsible investment offerings and superior client service,” said Joe Machi, director of alliances at Federated Hermes. “As the investment management landscape evolves, firms approach us about opportunities for business transactions that can help them meet their firm’s strategic goals and benefit their shareholders, fund shareholders and clients. We continue to look for opportunities with insurers, banks, broker-dealers and investment advisors as they evaluate their long-term plans.”
The agreement involves the following fund assets:

 
Hancock Horizon funds

Net assets
(in millions)*

 
Federated Hermes funds

Net assets
(in millions)*

Hancock Horizon BurkenroadSmall Cap Fund

$140

Federated Hermes MDT SmallCap Core Fund

$951

Hancock Horizon DiversifiedIncome Fund

$34

Federated Hermes CapitalIncome Fund

$1,000

Hancock Horizon DiversifiedInternational Fund

$230

Federated Hermes InternationalLeaders Fund

$1,059

Hancock Horizon Dynamic AssetAllocation Fund

$20

Federated Hermes GlobalAllocation Fund

$405

Hancock Horizon InternationalSmall Cap Fund

$30

Federated Hermes InternationalSmall-Mid Company Fund

$169

Hancock Horizon Louisiana Tax-Free Income Fund

$6

Federated Hermes MunicipalBond Fund, Inc.

$323

Hancock Horizon Microcap Fund

$14

Federated MDT Small Cap CoreFund

$951

Hancock Horizon Mississippi Tax-Free Income Fund

$12

Federated Hermes MunicipalBond Fund, Inc.

$323

Hancock Horizon QuantitativeLong/Short Fund

$83
 

Federated Hermes MDT MarketNeutral Fund

**

*As of March 31, 2021** Federated Hermes MDT Market Neutral Fund is subject to registration.  Fund will not be offered until it is effective and the reorganization is completed. The Federated Hermes MDT team has managed the market neutral strategy in a private fund context for more than 20 years.

Federated Hermes, Inc. is a leading global investment manager with $619.4 billion in assets under management as of Dec. 31, 2020. Guided by our conviction that responsible investing is the best way to create wealth over the long term, our investment solutions span equity, fixed-income, alternative/private markets, multi-asset and liquidity management strategies. Providing world-class active investment management and engagement services to more than 11,000 institutions and intermediaries, our clients include corporations, government entities, insurance companies, foundations and endowments, banks and broker/dealers. Headquartered in Pittsburgh, Federated Hermes’ more than 1,900 employees include those in London, New York, Boston and offices worldwide. For more information, visit FederatedHermes.com.
Horizon Advisers is an unincorporated division of Hancock Whitney Bank (established 1899), which is a wholly owned subsidiary of Hancock Whitney Corporation. Hancock Whitney Bank manages assets for institutional and high net worth clients including pension plans, endowments, foundations, government entities, corporations, trusts and estates. For more information, visit hancockhorizon.com.
Certain statements in this press release, such as those related to the structure of the transaction, asset transition levels, future transaction prospects for Federated Hermes, the meeting or closing dates of the transaction and performance objectives, constitute forward-looking statements, which involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the company, or industry results, to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Other risks and uncertainties include the possibility that Federated Hermes does not successfully complete the acquisition or completes the transaction in a manner or timetable different from that described above, as well as the risk factors discussed in the company’s annual and quarterly reports as filed with the Securities and Exchange Commission. As a result, no assurance can be given as to future results, levels of activity, performance or achievements, and neither the company nor any other person assumes responsibility for the accuracy and completeness of such statements in the future.

Federated Securities Corp. is distributor of the Federated Hermes funds.
Investors should carefully consider each fund’s investment objectives, risks, charges and expenses before investing. To obtain a summary prospectus or prospectus containing this and other information, contact Federated Hermes or view the prospectus provided at FederatedInvestors.com. Please carefully read the summary prospectus or prospectus before investing.
A prospectus/proxy statement with respect to the proposed transaction will be mailed to shareholders of the Hancock Horizon Funds and filed with the Securities and Exchange Commission (SEC). The SEC has not approved or disapproved these fund securities or passed upon the adequacy of the fund’s prospectus/proxy statement.  Any representation to the contrary is a criminal offense.  Additional information regarding the interests of participants in the solicitation of proxies in connection with the proposed fund prospectus/proxy statement will be included in, or incorporated into, the prospectus/proxy statement that the funds intend to file with the SEC. The foregoing does not constitute an offering of any securities for sale. This press release mentions certain reorganization, which, if approved by fund shareholders, would be conducted pursuant to an agreement and plan of reorganization. The prospectus/proxy statement will constitute neither an offer to sell securities, nor will it constitute a solicitation of an offer to buy securities, in any state where such offer or sale is not permitted.
Investors are urged to read the prospectus/proxy statement because it contains important information. The prospectus/proxy statement and other relevant documents will be available free of charge on the SEC’s Web site at www.sec.gov or by calling 1-800-341-7400. 
1As of March 31, 2021

View original content:http://www.prnewswire.com/news-releases/federated-hermes-inc-and-horizon-advisers-announce-agreement-to-transition-approximately-568-million-in-equity-and-fixed-income-fund-assets-301277146.html
SOURCE Federated Hermes, Inc.

[…]

Read More…

The MarketWatch News Department was not involved in the creation of this content.
Vancouver, British Columbia, Apr 26, 2021 (Newsfile Corp via COMTEX) — Vancouver, British Columbia–(Newsfile Corp. – April 26, 2021) – EMX Royalty Corporation (NYSE American: EMX) (TSXV: EMX (FSE: 6E9)(the “Company” or “EMX”) announces today that it has filed a preliminary short form base shelf prospectus (the “Base Shelf Prospectus”) with the securities commissions in each of the provinces and territories of Canada and a corresponding shelf registration statement on Form F-10 (the “Registration Statement”) with the United States Securities and Exchange Commission.

The Base Shelf Prospectus and Registration Statement, when made final and effective, will enable the Company to make offerings of up to C$200 million of common shares, debt securities, warrants, subscription receipts, units, or any combination thereof, during the 25-month period that ‎the Base Shelf Prospectus and Registration Statement remain valid. The specific terms of any offering will ‎be established in a prospectus supplement to the Base Shelf Prospectus, which will be filed with the applicable Canadian and U.S. securities ‎regulatory authorities in connection with any such offering. Unless otherwise specified in the prospectus supplement relating to a particular offering of securities, the net proceeds from any sale of securities may be used by EMX for general corporate purposes, including funding ongoing operations and/or working capital requirements, to repay indebtedness outstanding from time to time, and to fund capital projects and potential future acquisitions.
The Registration Statement filed with the SEC has not yet become effective. No securities may be sold, nor may offers to buy be accepted, prior to the time the Registration Statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any province, territory, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such province, territory state or jurisdiction.
Copies of the Base Shelf Prospectus and Registration Statement can be found under the Company’s profile on SEDAR at www.sedar.com and EDGAR at www.sec.gov, respectively. A copy of the Base Shelf Prospectus and Registration Statement may also be obtained from the Secretary of the Company at Suite 501 – 543 Granville Street, Vancouver, British Columbia V6C 1X8, Canada.
About EMX.EMX is a precious and base metals royalty company. EMX’s investors are provided with discovery, development, and commodity price optionality, while limiting exposure to risks inherent to operating companies. The Company’s common shares are listed on the NYSE American Exchange and the TSX Venture Exchange under the symbol EMX. See www.EMXroyalty.comfor more information.
For further information contact:
David M. ColePresident and Chief Executive OfficerPhone: (303) [email protected] 
Scott CloseDirector of Investor RelationsPhone: (303) [email protected]
Isabel BelgerInvestor Relations (Europe)Phone: +49 178 [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of EMX to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.
Specifically, this news release contains forward-looking statements relating to, but not limited to: obtaining a receipt for the Base Shelf Prospectus, for the amount and securities currently stated; and the filing of a prospectus supplement in the future. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including assumptions as to ability to obtain regulatory approval and the availability of financing opportunities in favourable market conditions. These foregoing lists are not exhaustive. Additional information on these and other factors which could affect the Company’s operations or financial results are included in the Company’s most recent annual information form and other public documents on file with the Canadian Securities regulatory authorities on www.sedar.com.
The forward-looking statements represent the Company’s views as at the date of this news release. There can be no assurance that forward-looking statements will prove to be accurate, as actual events and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on any forward-looking statement. The Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/81778

COMTEX_385113725/2523/2021-04-26T16:43:32
Is there a problem with this press release? Contact the source provider Comtex at [email protected]. You can also contact MarketWatch Customer Service via our Customer Center.
copyright (c) newsfile corp. 2021. all rights reserved

The MarketWatch News Department was not involved in the creation of this content.

[…]

Read More…

GRAPEVINE, Texas, April 26, 2021 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced that it has completed its previously announced “at-the-market” equity offering program (the “ATM Offering”).
GameStop disclosed on April 5, 2021 that it had filed a prospectus supplement with the U.S. Securities and Exchange Commission to offer and sell up to a maximum of 3,500,000 shares of its common stock from time to time through the ATM Offering. The Company ultimately sold 3,500,000 shares of common stock and generated aggregate gross proceeds before commissions and offering expenses of approximately $551,000,000. Net proceeds will be used to continue accelerating GameStop’s transformation as well as for general corporate purposes and further strengthening the Company’s balance sheet.
Earlier this month, GameStop disclosed that it issued an irrevocable notice of redemption to redeem $216.4 million in principal amount of its 10.0% Senior Notes due 2023 on April 30, 2021. This voluntary early redemption will cover the entire amount of the outstanding 10% Senior Notes, which represents all of the Company’s long-term debt.
About GameStop.
GameStop, a Fortune 500 company headquartered in Grapevine, Texas, is a leading specialty retailer offering games and entertainment products through its E-Commerce properties and thousands of stores. Visit www.GameStop.com to explore our products and offerings. Follow @GameStop and @GameStopCorp on Twitter and find us on Facebook at www.facebook.com/GameStop.
Cautionary Statement Regarding Forward-Looking Statements – Safe Harbor
This press release contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally, including statements about the ATM Offering and the use of proceeds therefrom, include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the SEC including, but not limited to, the Company’s Annual Report on Form 10-K for the fiscal year ended January 30, 2021, filed with the SEC on March 23, 2021.  All filings are available at www.sec.gov and on the Company’s website at www.GameStop.com.
Contact
GameStop Investor [email protected]
GameStop Public RelationsJoey [email protected]
or
ProfileGreg Marose / Charlotte Kiaiegamestop@profileadvisors.

[…]

Read More…

NEW YORK–(BUSINESS WIRE)–Apr 26, 2021–
Wells Fargo Securities LLC as index sponsor (the “Index Sponsor”) of the Wells Fargo ® Business Development Company Index (the “Original Index”), previously announced that the Original Index will be terminated after the close of trading on July 30, 2021.
The two ETRACS ETNs highlighted in Table-1 below (the “ETNs”) are currently linked to the performance of the Original Index. Effective after market close on July 30, 2021 (the “Effective Date”), the Original Index will be replaced with a successor index, the MVIS US Business Development Companies Index (the “Successor Index”). Pursuant to the terms of the ETNs, UBS Securities LLC, as security calculation agent for the ETNs, has determined that the Successor Index is comparable to the Original Index and approved the Successor Index as the successor index for the ETNs following the discontinuation of publication of the Original Index.

Table-1

In addition, the below adjustments will be made after market close on the Effective Date.
BDCZ ETN:

the Initial Index Level of the ETN will be adjusted to be equal to the Index Closing Level of the Successor Index on the Effective Date, times an Adjustment Factor. The Adjustment Factor will be equal to the original Initial Index Level divided by the Index Closing Level of the Original Index on the Effective Date

BDCX ETN:

the Last Reset Index Closing Level of the ETN will be adjusted to be equal to the Index Closing Level of the Successor Index on the Effective Date

UBS has been advised by its tax counsel that the change in the Index that is referenced by the ETNs should not trigger a disposition of the ETNs for US federal income tax purposes, and therefore a holder of ETNs should not be subject to any US federal income tax consequences as result of such change. UBS is not providing tax advice to holders of ETNs and such holders should consult with their tax advisors regarding the tax treatment of the ETNs.
About the Wells Fargo® Business Development Company Index
The Wells Fargo Business Development Company Index is a float-adjusted, capitalization-weighted Index that is intended to measure the performance of all Business Development Companies (“BDC”) that are listed on the New York Stock Exchange (“NYSE AMEX”) or NASDAQ and satisfy specified market capitalization and other eligibility requirements. To qualify as a BDC, the company must be registered with the Securities and Exchange Commission (“SEC”) and have elected to be regulated as a BDC under the Investment Company Act of 1940 (“1940 Act”). The Original Index was publicly disseminated starting from January 2011 and has no live performance history prior to that date.
About the MVIS US Business Development Companies Index
The MVIS US Business Development Companies Index is a modified market cap-weighted index that tracks the performance of the largest and most liquid companies which are treated as Business Development Companies (BDC) and are incorporated in the United States. To qualify as a BDC, a company must be organized under the law of and have its principal place of business in the United States, be registered with the SEC and have elected to be regulated as a BDC under the 1940 Act. The Successor Index was publicly disseminated starting from August 4, 2011 and has no live performance history prior to that date.
About ETRACS
ETRACS ETNs are senior unsecured notes issued by UBS AG, are traded on NYSE Arca, and can be bought and sold through a broker or financial advisor. An investment in ETRACS ETNs is subject to a number of risks, including the risk of loss of some or all of the investor’s principal, and is subject to the creditworthiness of UBS AG. Investors are not guaranteed any coupon or distribution amount under theETNs. We urge you to read the more detailed explanation of risks described under “Risk Factors” in the applicable prospectus supplement, or product supplement and pricing supplement, as applicable, for the ETRACS ETN.
UBS AG has filed a registration statement (including a prospectus and supplements thereto) with the Securities and Exchange Commission, or SEC, for the offerings of securities to which this communication relates. Before you invest, you should read the prospectus, along with the applicable prospectus, pricing, or product supplement to understand fully the terms of the securities and other considerations that are important in making a decision about investing in the ETRACS. The applicable offering document for each ETRACS may be obtained by clicking on the name of the ETN in the table above. You may also get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. The securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.
About UBS
UBS provides financial advice and solutions to wealthy, institutional and corporate clients worldwide, as well as private clients in Switzerland. UBS’s strategy is centered on our leading global wealth management business and our premier universal bank in Switzerland, enhanced by Asset Management and the Investment Bank. The bank focuses on businesses that have a strong competitive position in their targeted markets, are capital efficient, and have an attractive long-term structural growth or profitability outlook.
UBS is present in all major financial centers worldwide. It has offices in more than 50 regions and locations, with about 30% of its employees working in the Americas, 31% in Switzerland, 19% in the rest of Europe, the Middle East and Africa and 20% in Asia Pacific. UBS Group AG employs over 68,000 people around the world. Its shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).

This material is issued by UBS AG and/or any of its subsidiaries and/or any of its affiliates (“UBS”). Products and services mentioned in this material may not be available for residents of certain jurisdictions. Past performance is not necessarily indicative of future results. Please consult the restrictions relating to the product or service in question for further information. Activities with respect to US securities are conducted through UBS Securities LLC, a US broker/dealer. Member of SIPC ( http://www.sipc.org/ ).
ETRACS ETNs are sold only in conjunction with the relevant offering materials. UBS has filed a registration statement (including a prospectus, as supplemented by the applicable prospectus supplement, or product supplement and pricing supplement, for the offering of the ETRACS ETNs) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read these documents and any other documents that UBS has filed with the SEC for more complete information about UBS and the offering to which this communication relates. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, you can request the applicable prospectus supplement, or product supplement and pricing supplement, by calling toll-free (+1-877-387 2275). In the US, securities underwriting, trading and brokerage activities and M&A advisor activities are provided by UBS Securities LLC, a registered broker/dealer that is a wholly owned subsidiary of UBS AG, a member of the New York Stock Exchange and other principal exchanges, and a member of SIPC. UBS Financial Services Inc. is a registered broker/dealer and affiliate of UBS Securities LLC.
The ETRACS Wells Fargo BDC Index ETN Series B and the ETRACS Quarterly Pay 1.5x Leveraged Wells Fargo BDC Index ETN (“ETNs”) are not sponsored, endorsed, sold or promoted by Market Vectors Index Solutions GmbH (“Licensor”) and Licensor makes no representation or warranty, express or implied, to the owners of the ETNs or any member of the public regarding the advisability of investing in securities generally or in the ETNs particularly or the ability of the MVIS US Business Development Companies Index to track the performance of the US BDC market. The ETNs are not sponsored, endorsed, sold or promoted by Market Vectors Index Solutions GmbH (“Licensor”) and Licensor makes no representation or warranty, express or implied, to the owners of the ETNs or any member of the public regarding the advisability of investing in securities generally or in the ETNs particularly or the ability of the MVIS US Business Development Companies Index to track the performance of the US BDC market.
Wells Fargo Securities, Wells Fargo, and Wells Fargo Business Development Company Index are trademarks of Wells Fargo & Company and have been licensed for use for certain purposes by UBS. The ETRACS Exchange Traded Notes traded under the tickers BDCX and BDCZ are based on indices maintained by Wells Fargo Securities, LLC and are not issued, sponsored, endorsed or advised by Wells Fargo Securities, LLC, Wells Fargo & Company or their affiliates (“Wells”) and Wells makes no representation regarding whether such Products are suitable for investors generally or the advisability of trading in such Products. Wells does not guarantee that the Indices referenced by the Products have been accurately calculated or that the Indices appropriately represent particular investment strategies. Wells shall not have any liability for any error in the calculation of the Indices or for any infirmity in the Products. The Indices are calculated by third parties, including NYSE Arca, Inc., which are not affiliated with the issuer of the Products or with Wells and they do not approve, endorse, review or recommend the Indices, UBS or the Products.
NYSE Arca, Inc. (“NYSE Arca”), which acts as calculation agent for the Wells Fargo Business Development Company Index is not affiliated with UBS AG, Wells Fargo & Company or Wells Fargo Securities, LLC (together, “Wells Fargo”) and does not approve, endorse, review or recommend the Products.
UBS specifically prohibits the redistribution or reproduction of this material in whole or in part without the prior written permission of UBS and UBS accepts no liability whatsoever for the actions of third parties in this respect.
© UBS 2021. The key symbol, UBS and ETRACS are among the registered and unregistered trademarks of UBS. Other marks may be trademarks of their respective owners. All rights reserved.
1 Individual investors should instruct their broker/advisor/custodian to call us or should call together with their broker/advisor/custodian.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210426005717/en/
CONTACT: Media contact
Christina Aquilina
1-212-713-4488
[email protected]
Institutional Investor contact1
+1-877-387 2275
KEYWORD: NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BANKING PROFESSIONAL SERVICES FINANCE
SOURCE: UBS
Copyright Business Wire 2021.
PUB: 04/26/2021 04:05 PM/DISC: 04/26/2021 04:05 PM
http://www.businesswire.

[…]

Read More…

This coming Friday, April 30, 2021, the Securities and Exchange Commission (SEC) Small Business Capital Formation Advisory Committee will meet to discuss improving access to capital for underserved markets.
According to a note posted by the SEC, following its August 2020 meeting, the Committee presented findings encouraging the Commission to improve access to capital for underrepresented founders and investors. The April 30 meeting will revisit feedback previously shared while a presentation will be conducted by the Office of the Advocate for Small Business Capital Formation.
Following a discussion on potential solutions to improve access to capital, the Committee will deliberate on potential recommendations for the Commission.
In the past, the Committee has championed access to capital advocating for improvements to the securities crowdfunding ecosystem. The SEC does take into consideration recommendations provided by the Committee.
The proceedings will be live-streamed on the SEC website beginning at 10AM ET and concluding at 230PM ET. You can expect an appearance by the SEC Commissioners – including the recently confirmed new Chairman Gary Gensler.

[…]

Read More…

TipRanksRaymond James: These 3 Stocks Have Over 100% Upside on the HorizonWe’re now in the heart of earnings season, and investors are paying close attention as companies report their financial results from the first quarter of 2021. It’s a routine, in some ways, but in others, there has never been an earnings season quite like this. It’s the first one post-pandemic, but perhaps more importantly, the results are coming out during a time of nearly unprecedented government stimulus spending. There’s no real comparison to tell just how the inflows of cash are going to impact the bottom lines. Weighing in from Raymond James, strategist Tavis McCourt has put his finger on some of the key points for investors to take cognizance of. First, McCourt notes that the “S&P 500 2021 consensus EPS continues to move higher, almost on a daily basis, and has increased another 2% in the first two weeks of earnings season.” McCourt identifies the correct historical setting to the current conditions: “We normally see forward earnings revisions positive in the first 1-2 years of an economic recovery…” The comparison breaks down, however, as the estimate revisions just keep moving higher. “…analysts/management teams/this strategist, continue to underestimate the positive impact fiscal support (not ‘modelable’ as it’s never been done in this fashion before) is having on corporate earnings,” McCourt added. Bearing this in mind, we wanted to take a closer look at three stocks that have earned Raymond James’ stamp of approval. Accompanying a bullish rating, the firm’s analysts believe each could climb over 100% higher in the year ahead. Running the tickers through TipRanks’ database, we got all the details and learned what makes them such compelling plays. Landos Biopharma (LABP) We’ll start with a newcomer to the markets. Landos Biopharma held its IPO just this past February, when it started trading on the NASDAQ. The company is a clinical-stage biopharma firm, with a focus on autoimmune diseases. Landos uses a proprietary computational platform to develop new drug candidates, and has identified seven so far. The lead candidate is BT-11 (omilancor), a new treatment for patients with ulcerative colitis. BT-11 is a small molecule that targets the Lanthionine Synthetase C-Like 2 (LANCL2) pathway, an action designed to limit gastrointestinal impact. In January of this year, Landos reported positive results from BT-11’s Phase 2 proof-of-concept trial, with remission rates of 11.5% at week 12 for patients with once-daily oral dosing. Landos plans to expand the omilancor clinical trials, with a Phase 3 study in ulcerative colitis patients and a Phase 2 study in Crohn’s disease patients scheduled for later this year. The company’s other drug candidates are at earlier stages of the development pipeline, but it did have positive results to report from its candidate NX-13, another potential for ulcerative colitis. In a Phase 1 tolerability trial on healthy volunteers, the company reported no adverse results while meeting all primary and secondary endpoints. A Phase 1b study is planned for the second half of 2021. Among the fans is Raymond James analyst Steven Seedhouse, who sees the value factor in the company’s novel approach. “[New] mechanisms particularly in chronic immune disorders 1) carve out a potentially larger slice of the TAM pie in the leading indication (in this case UC) and 2) open the door to follow-on indications once the new mechanism is validated in one immune disorder. The value proposition for BT-11 in theory is it could be like Otezla (PDE4 inhibitor), which was acquired by Amgen for $11.2B net of tax benefits at 7x prior year (2018) sales of $1.6B,” Seedhouse opined. Looking ahead, to the longer term, Seedhouse believes that Landos has charted a profitable path. “Mild UC patients comprise >50% of patients with active disease. The vast majority drugs approved or in development for UC over the last 20 years target the highly competitive (but smaller) ‘moderate to severe’ patient market, while the larger ‘mild to moderate’ population remains largely untapped outside of 5-ASAs and corticosteroids. Substantial efficacy and safety in 5-ASA refractory mild to moderate patients will help BT-11 reach our estimated unadjusted peak sales of ~$1B,” the analyst added. In line with these comments, Seedhouse rates LABP an Outperform (i.e. Buy), and his $33 price target suggests room for an impressive 219% upside in the coming year. (To watch Seedhouse’s track record, click here) Landos Biopharma has caught the analysts’ attention in its short time as a public company, and already has 4 reviews on record. These break down to 3 Buys and 1 Hold, for a Strong Buy consensus rating. Shares are priced at $10.18, and their $25.50 average price target implies an upside of 146%. (See LABP stock analysis on TipRanks) Haemonetics Corporation (HAE) Haemonetics Corporation is major player in the blood business. It produces a full range of blood collection and separation products, along with the software to run the machines and service agreements to maintain them. The US market for blood products has hit $10.5 billion last year, and its largest segment, plasma products and blood components, makes up some 80% of that market. Haemonetics’ product line is designed to meet the needs of that segment. HAE shares showed steady growth from last August through this February – a sustained period of 85% share appreciate. Earlier this month, however, HAE dropped 35%, to its lowest level in over three years, on news that CSL Pharma had declared intent not to renew its supply agreement with Haemonetics. The agreement, for supply and use of the PCS2 plasma collection system, provided Haemonetics with $117 million in revenue – or nearly 12% of the company’s total top line. In addition to the lost revenue, Haemonetics will have to swallow an additional $32 million in one-time losses related to the cancellation. The current supply agreement expires in June of next year. Analyst Lawrence Keusch, watching Haemonetics for Raymond James, saw fit to maintain his Outperform (i.e. Buy) rating on the stock, even after the CSL announcement. “We concede that Haemonetics has turned into a ‘show me’ story as it will be important for investors to understand the evolution of the corporate strategy in light of the loss of the CSL contract… we believe that Haemonetics can mitigate the estimated $0.85 impact to earnings from the contract loss (the company has ~14 months to right-size the organization) and move toward additional market share gains. We anticipate that it will take some time to gain visibility on a renewed course of growth,” Keusch noted. Keusch is willing to give HAE the time it needs to recover and return to a growth trajectory, and his $155 price target shows the extent of his confidence – a 128% upside for the stock over the next 12 months. (To watch Keusch’s track record, click here) Overall, Haemonetics shows a 5 to 2 breakdown in Buy versus Hold recommendations from the Wall Street analysts, giving HAE shares a Moderate Buy consensus rating. The stock has a $122 average price target, suggesting ~79% upside from the current trading price of $67.96. (See HAE stock analysis on TipRanks) Maxeon Solar Technologies (MAXN) Let’s shift gears, and look at the solar technology sector. Maxeon manufactures and sells solar panels world-wide, under the SunPower brand outside the US and in its own name inside the States. The company spun off of SunPower last summer, when the parent company split off its manufacturing business. Maxeon, the spin off company, is a solar panel maker, with a product line worth $1.2 billion in annual revenue, more than 900 patents in the solar industry, and over 1,100 sales and installation partners operating in over 100 countries. In the fourth quarter of 2021, the last one reported, Maxeon showed a solid sequential revenue gain, from $207 million to $246 million, an 18% gain. Earnings, which had been deeply negative in Q3 – at a $2.73 per share loss – were positive in Q4, when EPS came in at 11 cents. Raymond James’ Pavel Molchanov, rated 5-stars by TipRanks, is impressed by the company’s overall position in the market, and sees positives outweighing negatives. “This is a commodity story, with a near-term margin structure that is weighed down by legacy polysilicon supply. We are fans of the company’s above-average exposure to the European market, soon to be bolstered by the European Climate Law; as well as its joint venture participation in China, whose already world-leading PV newbuilds may get a further boost from the newly launched carbon trading program,” Molchanov wrote. To this end, Molchanov rates MAXN an Outperform (i.e. Buy), and sets a $45 price target indicating room for 127% growth in the year ahead. (To watch Molchanov’s track record, click here) MAXN shares have managed to slip under the radar so far, and have only garnered 2 recent reviews; Buy and Hold. The shares are priced at $19.86, with a $34 average target that indicates room for ~71% growth by year’s end. (See MAXN stock analysis on TipRanks) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

[…]

Read More…

The Securities and Exchange Commission’s Small Business Capital Formation Advisory Committee will meet on Friday, April 30, to home in on solutions to increase access to capital for underrepresented founders and investors from smaller, regional funds.
Following its August 2020 meeting, the Committee presented findings encouraging the Commission to improve access to capital for underrepresented founders and investors. The April 30 discussion will revisit feedback shared during prior meetings and will include a presentation from the Office of the Advocate for Small Business Capital Formation highlighting data quantifying differential access to capital across demographic groups and geographies.  Following discussion on potential solutions to improve equitable access to capital, the Committee will deliberate on potential recommendations. The full agenda for the meeting is available with other meeting materials on the Committee’s webpage.
How to Listen: The Committee meeting will take place from 10 a.m. to 2:30 p.m. ET and will be webcast live on SEC.gov. The webcast will be archived on the Committee’s webpage for later viewing.
About the Committee: The Committee was established by Congress to provide the Commission with advice and recommendations on Commission rules, regulations, and policy matters relating to small businesses, from privately-held emerging companies to smaller public companies. The Committee has recently informed the Commission on a number of pertinent rulemaking and policy priorities, providing valued feedback into the regulatory process. Additional information on the Committee, including its members, is available on the Committee webpage.

[…]

Read More…

With deep insight into traders’ needs, leading CFD broker, EuropeStocks, stays ahead of the pack by offering Exchange Traded Funds (ETF) CFDs. Committed to revolutionising trading and offering easy access to the global markets for everyone, the firm also offers CFDs on stocks, indices, forex pairs and commodities. Its services are also accessible through an intuitive and user-friendly app.
With ETF CFDs, traders can potentially ensure portfolio diversification and risk management with a single financial instrument.

Trading in ETF CFDs
ETFs CFDs could garner the interest of both institutional and retail investors due to their characteristics, including potentially low cost of trading and potential ease of portfolio diversification. For example, to trade stocks directly investors would need a large capital layout whereas with ETF CFDs, traders only need to fund a fraction of the total trading amount, due to the availability of leverage. However, it shall be noted that trading with leverage involves a greater risk.
With ETF CFDs as traders gain exposure to an entire segment of the market instead of investing in only one stock. Should any one stock in the ETF underperform, the performance of the other stocks in the fund could mitigate losses. Also, with ETF CFDs traders are speculating on price direction via a futures contract, they don’t need to take ownership of the underlying asset.
Why EuropeStocks is One of the Fastest Growing Online Investment Portals
The key to success for EuropeStocks has been the company’s focus on redefining trading for all levels of experience.

Cutting-Edge App: The app has specifically been developed so that it offers as much support to a beginner as it does to advanced traders, while remaining easy-to-use and intuitive. Also, with the user-friendly app, traders are guided along every step, right from placing orders to keeping track of all open positions and investments.
Commission-Free Trading: The company offers three ways to trade ETF CFDs – via Zero Orders, Market Orders and Limit Orders. Zero Orders are completely commission-free for ETFs. On the other hand, Market and Limit Orders carry a fixed fee of just €1. This ensures that trading costs do not cut into traders’ earnings.
Client Safety: The company securely stores all client funds in segregated bank accounts, separate from the firm’s own funds. Under no circumstances can the firm use client funds for its own needs. Funds are further protected under the Investor Compensation Fund, which covers retail clients up to a total of €20,000.
Educational Resources: To help clients make informed investment decisions, EuropeStocks offers a wide range of educational articles and market analysis.

Most importantly, EuropeStocks is regulated by the Cyprus Securities and Exchange Commission (CySEC) under license number 258/14; and therefore, the Company is required to be compliant with the Markets in Financial Instruments Directive (MiFID II). This helps give peace of mind to clients, allowing them to focus on their trading.
To discover more about the ETF CFDs and other offerings from the company, contact the EuropeStocks team.

Risk Disclaimer:
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 83.35% of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
We highly recommend that you do not invest more money than you can afford to lose to avoid significant financial problems in the case of losses. Please make sure you define the maximum risk acceptable for yourself.

[…]

Read More…

So I came on board with CeramicSpeed and became the CTO.

[…]

Read More…